Does Regeneron support research and development programs?
We proudly support a broad range of programs that offer support and resources to researchers, healthcare providers, patients and their advocates, as well as our local communities. For funding opportunities in the following areas, please visit the Regeneron Request for Funding System:
What is the Patient Assistance Support Program (pass)?
The Patient Assistance Support program, PASS (the “Program”), is an assistance program supported by Regeneron Pharmaceuticals, Inc., and its aliates and agents that provides qualifying patients with Regeneron products at no cost. Authorization to Disclose Information:
What challenges have we faced at Regeneron?
we rise to any challenge with characteristic drive and a focus on scientific innovation. We’re applying our novel technologies to respond swiftly to public health infectious disease outbreaks like Ebola, MERS and COVID-19. Alumni of Regeneron’s STEM programs and competitions have won National Medals of Science, Fields Medals and Nobel Prizes.
See more
What diseases is Regeneron used for?
Our clinical portfolio currently includes antibody candidates for over 30 types of cancer, including cutaneous squamous cell carcinoma, basal cell carcinoma, non-small cell lung cancer, cervical, diffuse large B-cell lymphoma, follicular lymphoma, multiple myeloma, ovarian, prostate cancers and many more.
What type of company is Regeneron?
biotechnology companyRegeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases.
Where is the company Regeneron located?
Westchester County, New YorkRegeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.
What country is Regeneron from?
Reggaetón had its conception in the 1980s when Jamaican workers traveled to Panama to help build the Panama Canal and reggae was adapted to the Spanish-speaking culture. In the 1990s, the genre made its way to Puerto Rico via Jamaican immigrants.
Does Regeneron pay well?
Salaries at Regeneron Inc range from an average of $59,332 to $173,077 a year. Regeneron Inc employees with the job title Research Scientist make the most with an average annual salary of $101,422, while employees with the title Research Associate, Biotechnology make the least with an average annual salary of $73,273.
Is Regeneron a good company?
Regeneron Ranked #1 Biopharma Employer for Sixth Time by Science Magazine. Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Science magazine has named the company the world's number one employer in its annual survey of the biotech and pharmaceutical industry.
Does Regeneron help Covid?
Receiving REGEN-COV may benefit certain people with COVID-19 and may help prevent certain people who have been exposed to someone who is infected with SARS-CoV-2 from getting SARS-CoV-2 infection, or may prevent certain people who are at high risk of exposure to someone who is infected with SARS-CoV-2 from getting SARS ...
How many employees does Regeneron have?
7,126Company InfoRank last year75HQ locationTarrytown, N.Y.Employees7,126Job openings (as of February 2020)531IndustryBiotechnology & Pharmaceuticals6 more rows
Is Regeneron Pharmaceuticals a good company to work for?
Is Regeneron a good company to work for? Regeneron has an overall rating of 4.0 out of 5, based on over 1,476 reviews left anonymously by employees. 78% of employees would recommend working at Regeneron to a friend and 84% have a positive outlook for the business. This rating has been stable over the past 12 months.
What products do Regeneron make?
Our FDA-approved medicines are only the beginning of our long-term commitment to solve the human body's most complex mysteries.DUPIXENT® (dupilumab) Injection. Prescribing Information. Patient Information. ... EVKEEZA® (evinacumab-dgnb) Injection. Prescribing Information. ... EYLEA® (aflibercept) Injection. Prescribing Information.
Who are Regeneron competitors?
Regeneron Pharmaceuticals's competitors and similar companies include Intersect ENT, Catalent, Bristol-Myers Squibb, Idorsia, Amgen, Sanofi and Biogen.
Is Regeneron Pharmaceuticals a good company to work for?
Is Regeneron a good company to work for? Regeneron has an overall rating of 4.0 out of 5, based on over 1,476 reviews left anonymously by employees. 78% of employees would recommend working at Regeneron to a friend and 84% have a positive outlook for the business. This rating has been stable over the past 12 months.
Is Regeneron a Fortune 500 company?
Regeneron Pharmaceuticals | 2022 Fortune 500 | Fortune.
What is Regeneron's belief?
We believe that patients should have access to appropriate, evidence-based medicines to get them to the best health. Patients are singularly able to tell their story about access challenges and how these obstacles can impact their daily lives and health. Regeneron has supported advocacy training, distribution of access tools, town halls and coalition building for patients and caregivers so that they can have a greater chance for successful outcomes. To submit a request for funding, visit our grants portal.
What is compassionate use policy?
Our Compassionate Use Policy gives certain patients who have serious or life-threatening conditions access to a potentially beneficial medicine when no comparable or satisfactory alternative therapy options or clinical trials area available. Compassionate Use, also known as expanded access in the U.S., is an approved pathway that, by design, is meant for exceptional circumstances. Our Compassionate Use program has certain established criteria and each request is reviewed by Regeneron’s Compassionate Use Committee.
Is Regeneron a fast response?
To address emerging or rapidly spreading infectious diseases, Regeneron has applied our VelociSuite ® technologies in a ‘rapid response’ manner that parallel tracks certain steps and speeds hand-offs between groups in order to advance novel antibody treatments extremely quickly. We’ve been proud to apply our homegrown technologies and novel scientific approach to respond to public health challenges like Ebola, Middle East Respiratory Syndrome (MERS) and COVID-19.
Scientific trailblazers
Following the science leads to unexpected breakthroughs and diverse areas of study.
Developing new medicines for serious diseases
A primarily ‘homegrown’ pipeline of potential medicines for dozens of diseases.
Over 30 years of challenges and triumphs
Our story is unusual, with remarkable consistency of leadership and purpose in our efforts to accelerate the drug discovery and development process.
